CRESCITA THERAPEUTICS INC (CTX.CA) Stock Price & Overview
TSX:CTX • CA2258471028
Current stock price
The current stock price of CTX.CA is 0.75 CAD. Today CTX.CA is down by 0%. In the past month the price increased by 61.29%. In the past year, price increased by 33.93%.
CTX.CA Key Statistics
- Market Cap
- 13.958M
- P/E
- 37.50
- Fwd P/E
- N/A
- EPS (TTM)
- 0.02
- Dividend Yield
- N/A
CTX.CA Stock Performance
CTX.CA Stock Chart
CTX.CA Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to CTX.CA. When comparing the yearly performance of all stocks, CTX.CA is one of the better performing stocks in the market, outperforming 79.69% of all stocks.
CTX.CA Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to CTX.CA. CTX.CA has a great financial health rating, but its profitability evaluates not so good.
CTX.CA Earnings
CTX.CA Forecast & Estimates
CTX.CA Groups
Sector & Classification
CTX.CA Financial Highlights
Over the last trailing twelve months CTX.CA reported a non-GAAP Earnings per Share(EPS) of 0.02. The EPS increased by 117.32% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 2.07% | ||
| ROA | 2.13% | ||
| ROE | 2.81% | ||
| Debt/Equity | 0 |
CTX.CA Ownership
CTX.CA Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| BHC | BAUSCH HEALTH COS INC | 1.29 | 2.757B | ||
| CRON | CRONOS GROUP INC | 40.04 | 1.346B | ||
| TLRY | TILRAY BRANDS INC | N/A | 1.086B | ||
| DHT-UN | DRI HEALTHCARE TRUST | 5.21 | 909.865M | ||
| GUD | KNIGHT THERAPEUTICS INC | 157.37 | 749.929M | ||
| DHT-U | DRI HEALTHCARE TRUST | 3.72 | 649.118M | ||
| WEED | CANOPY GROWTH CORP | N/A | 606.18M | ||
| CPH | CIPHER PHARMACEUTICALS INC | 22.42 | 470.966M | ||
| TSND | TERRASCEND CORP | N/A | 327.378M | ||
| HITI | HIGH TIDE INC | 10.38 | 277.764M | ||
| OGI | ORGANIGRAM GLOBAL INC | 28.38 | 274.043M | ||
| ACB | AURORA CANNABIS INC | 58.91 | 272.775M | ||
| CRDL | CARDIOL THERAPEUTICS INC-A | N/A | 210.071M |
Related stock screener links
View all stocks in the Pharmaceuticals Industry | View all stocks in the Health Care Sector | View all stocks on the Toronto Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the Canadian exchanges | Find stocks with similar Fundamental rating on the Canadian exchanges | Find the competitors with the best technical ratings on the Canadian exchanges | Find the competitors with the best fundamentals on the Canadian exchanges | Find the competitors with the best valuation on the Canadian exchanges | Find the competitors with the best dividend on the Canadian exchanges | Find the competitors with the best analyst ratings on the Canadian exchanges
About CTX.CA
Company Profile
Crescita Therapeutics, Inc. engages in the provision of non-prescription skincare products. The company is headquartered in Laval, Quebec and currently employs 75 full-time employees. The company went IPO on 2016-03-07. The company offers a portfolio of science-based non-prescription skincare products and early to commercial stage prescription products. The company operates in three segments: Commercial Skincare, Licensing and Royalties, and Manufacturing and Services. The Commercial Skincare segment manufactures and sells branded non-prescription skincare products for the Canadian and international markets. The company also commercializes Pliaglis, NCTF Boost 135 HA, ART FILLER, and Obagi Medical in Canada. The Licensing and Royalties segment is engaged in licensing the intellectual property related to Pliaglis or its transdermal delivery technologies. The Manufacturing and Services segment is engaged in the sale of topical products manufactured to client specifications under the Company’s contract development and manufacturing organization infrastructure, and product development services.
Company Info
IPO: 2016-03-07
CRESCITA THERAPEUTICS INC
2805, Place Louis R Renaud
Laval QUEBEC H7V 0A3 CA
CEO: Serge Verreault
Employees: 75
Phone: 18003610352
CRESCITA THERAPEUTICS INC / CTX.CA FAQ
What does CRESCITA THERAPEUTICS INC do?
Crescita Therapeutics, Inc. engages in the provision of non-prescription skincare products. The company is headquartered in Laval, Quebec and currently employs 75 full-time employees. The company went IPO on 2016-03-07. The company offers a portfolio of science-based non-prescription skincare products and early to commercial stage prescription products. The company operates in three segments: Commercial Skincare, Licensing and Royalties, and Manufacturing and Services. The Commercial Skincare segment manufactures and sells branded non-prescription skincare products for the Canadian and international markets. The company also commercializes Pliaglis, NCTF Boost 135 HA, ART FILLER, and Obagi Medical in Canada. The Licensing and Royalties segment is engaged in licensing the intellectual property related to Pliaglis or its transdermal delivery technologies. The Manufacturing and Services segment is engaged in the sale of topical products manufactured to client specifications under the Company’s contract development and manufacturing organization infrastructure, and product development services.
What is the stock price of CRESCITA THERAPEUTICS INC today?
The current stock price of CTX.CA is 0.75 CAD.
What is the dividend status of CRESCITA THERAPEUTICS INC?
CTX.CA does not pay a dividend.
What is the ChartMill technical and fundamental rating of CTX stock?
CTX.CA has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
Where is CRESCITA THERAPEUTICS INC (CTX.CA) stock traded?
CTX.CA stock is listed on the Toronto Stock Exchange exchange.